December 05, 2024--AstraZeneca’s IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

A study by researchers from the University of Liverpool and the Research Institute for Diagnostic Accuracy, Netherlands, has ...

As technology advances in the fight against cancer, Allegheny Health Network is using a new robotic tool to diagnose lung ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

Lung cancer remains the preeminent cancer in terms of mortality globally, primarily due to late-stage detection in many patients. Despite advancements in ...

A recent study reveals higher comorbidity rates among diverse patients undergoing lung cancer screening, indicating potential ...

Research Pinpoints Weakness in Lung Cancer's Defenses Feb. 10, 2025 — Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in ...

Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...

Researchers at Fred Hutch Cancer Center have discovered an overlooked mechanism driving aggressive breast and brain tumors ...

Immune checkpoint inhibitors (ICPis) have revolutionized the therapeutic landscape of lung cancer with unprecedented survival results in most of the ...

SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 ...